Columnist Juliet Taylor remembers her late husband, Jeff, on their anniversary, and reflects on the wonderful grandpa he ...

Despite the inaccessibility of an "accessible" bathroom stall, columnist Dagmar Munn finds the humor in the situation.

A new dashboard by the ALS Association offers free and open access to real-world data from more than 4,000 people affected by ...

Researchers have identified new blood and spinal fluid biomarkers that could help track ALS progression and monitor treatment ...

Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...

ALS is more common in some parts of the U.S. than others and it has a very strong geographic association with MS, a new study ...

Living with ALS has taken a toll, but columnist Kristin Neva feels like she is doing better now than she has in a long time.

The U.S. Food and Drug Administration (FDA) has granted orphan drug status to CK0803, a regulatory T-cell therapy being developed by Cellenkos for amyotrophic lateral sclerosis (ALS), with a goal of ...

Amyotrophic lateral sclerosis (ALS) is more common in some parts of the U.S. than others, and it has a very strong geographic association with multiple sclerosis (MS), a new study suggests. The ...